Age-dependent oral manifestations of neurofibromatosis type 1: a case-control study.
Autor: | Thota E; Panineeya Institute of Dental Sciences and Research Centre, Hyderabad, Telangana, India.; SVS Institute of Dental Sciences, Mahbubnagar, Telangana, India., Veeravalli JJ; Panineeya Institute of Dental Sciences and Research Centre, Hyderabad, Telangana, India.; SVS Institute of Dental Sciences, Mahbubnagar, Telangana, India., Manchala SK; Panineeya Institute of Dental Sciences and Research Centre, Hyderabad, Telangana, India., Lakkepuram BP; Panineeya Institute of Dental Sciences and Research Centre, Hyderabad, Telangana, India., Kodapaneni J; Panineeya Institute of Dental Sciences and Research Centre, Hyderabad, Telangana, India., Chen YW; Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan, ROC. yiwenchen@ntu.edu.tw.; Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan, ROC. yiwenchen@ntu.edu.tw., Wang LT; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Taiwan, ROC. lizwang@ntu.edu.tw., Ma KS; Department of Dentistry, National Taiwan University Hospital, Taipei, Taiwan, ROC. kevinskma@hep1.phys.ntu.edu.tw.; Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan, ROC. kevinskma@hep1.phys.ntu.edu.tw.; Graduate Institute of Biomedical Electronics and Bioinformatics, College of Electrical Engineering and Computer Science, National Taiwan University, Taipei, Taiwan, ROC. kevinskma@hep1.phys.ntu.edu.tw.; Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. kevinskma@hep1.phys.ntu.edu.tw. |
---|---|
Jazyk: | angličtina |
Zdroj: | Orphanet journal of rare diseases [Orphanet J Rare Dis] 2022 Mar 02; Vol. 17 (1), pp. 93. Date of Electronic Publication: 2022 Mar 02. |
DOI: | 10.1186/s13023-022-02223-x |
Abstrakt: | Introduction: Most craniofacial manifestations of neurofibromatosis type 1 (NF1) are considered as a result of tumor compression. We sought to determine salivary changes, caries, and periodontal complications in NF1 patients without tumors in the oral cavity. Objective and Methods: Eleven NF1 patients without tumors in the oral cavity and 29 matched controls without NF1 were enrolled in this case-control study. Demographic information, medical history, and data of intraoral examinations, including the Decayed, Missing, and Filled Teeth (DMFT) scores and Russel's periodontal index (PI), were recorded. The functional salivary analysis was performed for sialometry, salivary pH values, and amylase activity. Ingenuity Systems Pathway Analysis (IPA) was conducted to identify mutually activated pathways for NF1-associated oral complications. Results: NF1 patients were associated with periodontitis (OR = 1.40, 95% CI = 1.06-1.73, P = 0.04), gingivitis (OR = 1.55, 95% CI = 1.09-2.01, P = 0.0002), and decreased salivary flow rates (OR = 1.40, 95% CI = 1.05-1.76, P = 0.005). Periodontal destruction, salivary changes, and dental caries in NF1 patients were age-dependent. Subgroup analyses based on age stratification suggested that salivary flow rates and salivary amylase activities were significantly low in NF1 patients aged over 20 years and that salivary pH values, PI and DMFT scores were significantly high among NF1- controls aged over 20. All oral complications were not significantly presented in NF1 patients aged below 20 years. IPA analyses suggested that cellular mechanisms underlying NF1-associated oral complications involved chronic inflammatory pathways and fibrosis signaling pathway. Conclusion: NF1 patients without tumors in the oral cavity presented a comparatively high prevalence of age-dependent oral complications, including periodontal destruction and salivary gland dysfunction, which were associated with chronic inflammatory pathogenesis. (© 2022. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |